Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Gastric Cancer|Oesophageal Cancer|Breast Cancer|Squamous Cell Carcinoma of the Lung
Interventions: DRUG: AZD 4547
Sponsor: Royal Marsden NHS Foundation Trust
Collaborators: AstraZeneca